Known targets — ChEMBL curated mechanism
The experimentally established mechanism targets of Dicyclomine. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CHRM1 known ✓ | P11229 | 6/20 | 1.00 |
| ▸ | CHRM3 known ✓ | P20309 | 3/20 | 1.00 |
| ▸ | CYP3A4 | P08684 | 6/20 | 1.00 |
| ▸ | CHRM2 | P08172 | 6/20 | 1.00 |
| ▸ | LMNA | P02545 | 4/20 | 1.00 |
| ▸ | CYP1A2 | P05177 | 4/20 | 1.00 |
| ▸ | CYP2D6 | P10635 | 4/20 | 1.00 |
| ▸ | TSHR | P16473 | 4/20 | 1.00 |
| ▸ | SIGMAR1 | Q99720 | 3/20 | 1.00 |
| ▸ | CHRM4 | P08173 | 3/20 | 1.00 |
| ▸ | DRD1 | P21728 | 2/20 | 1.00 |
| ▸ | DRD3 | P35462 | 2/20 | 1.00 |
| ▸ | KCNH2 | Q12809 | 2/20 | 1.00 |
| ▸ | ABCB11 | O95342 | 1/20 | 1.00 |
| ▸ | CHRM5 | P08912 | 1/20 | 1.00 |
| ▸ | CYP2C9 | P11712 | 1/20 | 1.00 |
| ▸ | HRH2 | P25021 | 1/20 | 1.00 |
| ▸ | HTR2A | P28223 | 1/20 | 1.00 |
| ▸ | HTR2C | P28335 | 1/20 | 1.00 |
| ▸ | HRH1 | P35367 | 1/20 | 1.00 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Dicyclomine SCHEMBL10684080 | 0.99 | CYP3A4 (0.97) | CYP3A4CHRM2CHRM1LMNACYP1A2 | |
| Dicyclomine SCHEMBL20536388 | 0.99 | CYP3A4 (1.00) | CYP3A4CHRM2CHRM1LMNACYP1A2 | |
| Dicyclomine SCHEMBL41670 | 0.99 | CYP3A4 (1.00) | CYP3A4CHRM2CHRM1LMNACYP1A2 | |
| Dicyclomine SCHEMBL14322178 | 0.99 | CYP3A4 (0.97) | CYP3A4CHRM2CHRM1LMNACYP1A2 | |
| Dicyclomine SCHEMBL5501641 | 0.99 | CYP3A4 (1.00) | CYP3A4CHRM2CHRM1LMNACYP1A2 | |
| Dicyclomine SCHEMBL3051663 | 0.97 | CYP3A4 (0.95) | CYP3A4CHRM2CHRM1LMNACYP1A2 | |
| Dicyclomine SCHEMBL7023518 | 0.97 | CYP3A4 (0.97) | CYP3A4CHRM2CHRM1LMNACYP1A2 | |
| Dicyclomine SCHEMBL6285092 | 0.96 | CYP3A4 (0.95) | CYP3A4CHRM2CHRM1LMNACYP1A2 | |
| Dicyclomine SCHEMBL2481238 | 0.95 | CYP3A4 (0.90) | CYP3A4CHRM2CHRM1LMNACYP1A2 | |
| Dicyclomine SCHEMBL8082728 | 0.94 | CYP3A4 (0.90) | CYP3A4CHRM2CHRM1LMNACYP1A2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 9435 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2026100654-A1 | NUCLEIC ACID INTRODUCTION AID, NUCLEIC ACID INTRODUCTION AGENT, AND NUCLEIC ACID INTRODUCTION METHOD | 株式会社インファーマシア | 2026-05-15 | — | — | WO | claimed |
| EP-4736841-A1 | A MUCOADHESIVE LAYER FOR BUCCAL ADMINISTRATION OF AN ACTIVE PHARMACEUTICAL INGREDIENT | IQ medical GmbH (DE) | 2026-05-06 | — | — | EP | claimed |
| EP-4717276-A2 | OPHTHALMIC COMPOSITIONS COMPRISING LEVODOPA, AN ANTIOXIDANT AND AN AQUEOUS CARRIER | University of Canberra (AU) | 2026-04-01 | — | — | EP | claimed |
| EP-4706766-A2 | TOPICAL OPHTHALMOLOGICAL COMPOSITIONS | ADS Therapeutics LLC (US) | 2026-03-11 | — | — | EP | claimed |
| EP-4705511-A1 | DNA METHYLATION-BASED ALGORITHM TO DIAGNOSE IRRITABLE BOWEL SYNDROME AND OTHER GI CONDITIONS | The Regents of the University of California (US) | 2026-03-11 | — | — | EP | claimed |
| US-12550885-B2 | Red blood cell storage solutions, solution additives, and methods for improving the storage of red blood cells | UNIVERSITY OF CINCINNATI (US) | 2026-02-17 | — | — | US | claimed |
| EP-4689034-A1 | SURFACTANT COMPOSITION BASED ON A MIXTURE OF DIBASIC AMINO ACID ESTER AND GLYCINE BETAINE ESTER, AND USES THEREOF | Surfactgreen (FR) | 2026-02-11 | — | — | EP | claimed |
| EP-3507371-B1 | COMPOSITIONS FOR TREATING DISEASES AND DISORDERS OF THE NERVOUS SYSTEM | UNIV RUTGERS (US) | 2026-01-28 | — | — | EP | claimed |
| EP-4658278-A1 | SELECTIVE FIASMA TREATMENT | Valo Health, Inc. (US) | 2025-12-10 | — | — | EP | claimed |
| US-12485177-B2 | Topical ophthalmological compositions | ADS THERAPEUTICS LLC (US) | 2025-12-02 | — | — | US | claimed |
| WO-1995023591-A1 | ORAL VEHICLE COMPOSITIONS | THE PROCTER & GAMBLE COMPANY (US) | 1995-09-08 | — | — | WO | claimed |
| WO-1995009006-A1 | MONOGLYCERIDE/LACTATE ESTER PERMEATION ENHANCER | ALZA CORPORATION (US) | 1995-04-06 | — | — | WO | claimed |
| US-5288503-A | WATER-PERMEABLE DIFFUSION BARRIER OF POLYVINYL ALCOHOL | SRCHEM INCORPORATED (US) | 1994-02-22 | — | — | US | claimed |
| EP-0367746-B1 | Sustained release drug-resin complexes | RICHARDSON VICKS INC (US) | 1994-02-02 | — | — | EP | claimed |
| EP-0572932-A2 | Method and implant device for long term delivery of drugs | C.R. BARD, INC. (US) | 1993-12-08 | — | — | EP | claimed |
| US-5260066-A | Cryogel bandage containing therapeutic agent | SRCHEM INCORPORATED (US) | 1993-11-09 | — | — | US | claimed |
| EP-0465234-A1 | Pharmaceutical compositions and methods for alleviating gastrointestinal distress symptoms induced by nonsteroidal anti-inflammatory drugs | McNEIL-PPC, INC. (US) | 1992-01-08 | — | — | EP | claimed |
| US-4996047-A | Sustained release drug-resin complexes | RICHARDSON-VICKS, INC. (US) | 1991-02-26 | — | — | US | claimed |
| WO-1990015423-A1 | SUPERPARAMAGNETIC LIQUID COLLOIDS | OMNI QUEST CORPORATION (US) | 1990-12-13 | — | — | WO | claimed |
| US-4952402-A | EDIBLE TASTE-MASKED DRUGS; MICROMATRIX ACTIVE MATERIAL COATED WITH NONTOXIC POLYMER; LIQUIDS; TABLETS | ELAN CORPORATION, P.L.C. (IE) | 1990-08-28 | — | — | US | claimed |